November 16, 2010- by Steven E. Greer, MD
We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible for approving drugs and monitoring for safety.
In Part 1, she reviews her responsibilities as Director over a period of time spanning both Republican and Democratic administrations. The recent ACA healthcare reform law and the 2007 FDAAA have radically changed how the FDA is handling safety of drugs.